...
首页> 外文期刊>Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology >123)I-mIBG Scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials.
【24h】

123)I-mIBG Scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials.

机译:123)I-mIBG闪烁显像术可预测心力衰竭患者不良心脏结局的风险:两项前瞻性多中心国际试验的设计。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) consists of two identical prospective open-label, multicenter, phase 3 studies (MBG311 and MBG312) evaluating the prognostic usefulness of (123)I-mIBG scintigraphy for identifying subjects with heart failure who will experience a major adverse cardiac event. METHODS: Subjects with NYHA class II and III heart failure and left ventricular ejection fraction
机译:背景:ADMIRE-HF(用于心力衰竭风险评估的AdreView心肌成像)由两个相同的前瞻性开放标签,多中心,3期研究(MBG311和MBG312)组成,评估(123)I-mIBG闪烁显像对确定受试者的预后有效性心力衰竭的人将经历严重的心脏不良事件。方法:NYHA II级和III级心力衰竭且左心室射血分数

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号